AI Assistant
Blog
Pricing
Log In
Sign Up
Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.